Results 31 to 40 of about 5,711,116 (385)

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

New England Journal of Medicine, 2010
BACKGROUND Sipuleucel-T, an autologous active cellular immunotherapy, has shown evidence of efficacy in reducing the risk of death among men with metastatic castration-resistant prostate cancer.
P. Kantoff, C. Higano, N. Shore, E. Berger, E. Small, D. Penson, C. Redfern, A. Ferrari, R. Dreicer, R. Sims, Yi Xu, M. Frohlich, P. Schellhammer   +12 more
semanticscholar   +1 more source

Cross-cultural differences in men on active surveillance’ anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study

BMC Urology, 2022
Background Men diagnosed with localized prostate cancer (PCa) on active surveillance (AS) have shown to cope with anxiety caused by living with an ‘untreated cancer’ and different factors can influence the tolerance level for anxiety in these patients ...
Paola Dordoni, Sebastiaan Remmers, Riccardo Valdagni, Lara Bellardita, Letizia De Luca, Fabio Badenchini, Cristina Marenghi, Monique J. Roobol, Lionne D. F. Venderbos   +8 more
doaj   +1 more source

The human gastrointestinal microbiota and prostate cancer development and treatment [PDF]

, 2020
The human gastrointestinal microbiome contains commensal bacteria and other microbiota that have been gaining increasing attention in the context of cancer development and response to treatment.
Alanee, Alexander, Althuis, Amirian, Arthur, Bostwick, Boursi, Buti, Cheng, Cimadamore, Cockburn, Costello, Cuevas-Ramos, Daniels, De Marzo, De Marzo, Dennis, Dominguez-Bello, Eckburg, Elkahwaji, Elkrief, Figueiredo, Gill, Golombos, Goodman, Graessler, Haller, Hamada, Hatakeyama, Hunter, Iida, Kamps, Lampe, Lara-Tejero, Lenoir, Liss, Masood, Meldrum, Miquel, Miyake, Montassier, Mosca, Mouraviev, Musso, Nakai, O'Hara, Olsson, Paulos, Plottel, Porter, Poutahidis, Punnen, Qin, Redman, Ridlon, Roberts, Roy, Russell, Sfanos, Siegel, Smith, Sokol, Sokol, Sonn, The Global Cancer Observatory, Tulstrup, Vande Voorde, Viaud, Vivarelli, Vétizou, Wilson   +70 more
core   +1 more source

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.

New England Journal of Medicine, 2017
BACKGROUND The comparative effectiveness of treatments for prostate cancer that is detected by prostate-specific antigen (PSA) testing remains uncertain.
F. C. Hamdy, J. Donovan, J. Lane, M. Mason, C. Metcalfe, P. Holding, M. Davis, T. Peters, E. Turner, Richard M. Martin, J. Oxley, M. Robinson, J. Staffurth, E. Walsh, P. Bollina, J. Catto, A. Doble, A. Doherty, D. Gillatt, R. Kockelbergh, H. Kynaston, A. Paul, P. Powell, S. Prescott, D. Rosario, E. Rowe, D. E. Neal, D. E. Neal   +27 more
semanticscholar   +1 more source

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.

New England Journal of Medicine, 2020
BACKGROUND The use of 12-core systematic prostate biopsy is associated with diagnostic inaccuracy that contributes to both overdiagnosis and underdiagnosis of prostate cancer.
M. Ahdoot, Andrew R Wilbur, Sarah E Reese, A. Lebastchi, Sherif Mehralivand, Patrick T. Gomella, Jonathan B Bloom, Sandeep Gurram, M. Siddiqui, P. Pinsky, H. Parnes, W. Linehan, M. Merino, P. Choyke, J. Shih, B. Turkbey, B. Wood, P. Pinto   +17 more
semanticscholar   +1 more source

Diagnostic Age, Age at Death and Stage Migration in Men Dying with or from Prostate Cancer in Denmark

Diagnostics, 2022
The impact of changes in diagnostic activity and treatment options on prostate cancer epidemiology remains a subject of debate. Newly published long-term survival outcomes may not represent contemporary patients and new perspectives are in demand.
Marc Casper Meineche Andersen, Hein Vincent Stroomberg, Klaus Brasso, John Thomas Helgstrand, Andreas Røder   +4 more
doaj   +1 more source

Regulation of Phosphatase Homologue of Tensin Protein Expression by Bone Morphogenetic Proteins in Prostate Epithelial Cells [PDF]

, 2010
Phosphatase homologue of tensin (PTEN) is the key endogenous inhibitor of phosphoinositide signaling and is the most commonly mutated gene in human prostate cancer.
Dan Theodorescu, Travis Jerde, Wade Bushman, Zhong Wu   +3 more
core   +2 more sources

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Ca, 2018
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across ...
F. Bray, J. Ferlay, I. Soerjomataram, R. Siegel, Lindsey A. Torre, A. Jemal   +5 more
semanticscholar   +1 more source

Cancer Statistics, 2021

Ca, 2021
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence.
R. Siegel, K. D. Miller, Hannah E Fuchs, A. Jemal   +3 more
semanticscholar   +1 more source

CANCER OF THE PROSTATE [PDF]

Journal of the American Medical Association, 1914
The facts that the general subject of cancer presents even to-day one of our most serious and unsolved problems; that cancer of the prostate is a comparatively frequent and exceedingly distressful form of the disease; and the probability that by a more wide-spread application of the present available knowledge of this pathologic process the prevalent ...
openaire   +3 more sources